For the most frequent uncommon mutations , 14 ( 778 % , 95 % CI 524-936 ) patients with Gly719Xaa had an objective response , as did nine ( 563 % , 299-802 ) with Leu861Gln , and eight ( 1000 % , 631-1000 ) with Ser768Ile .